Nifty
Sensex
:
:
20855.10
69296.14
168.30 (0.81%)
431.02 (0.63%)

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 532331 | NSE: AJANTPHARM

1966.85
05-Dec-2023
  • Open
  • High
  • Low
  • Previous Close
  •  1959.90
  •  1981.65
  •  1920.10
  •  1959.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  101775
  •  1986.15
  •  1998.70
  •  1131.70

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 24,775.79
  • 37.36
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 24,513.93
  • 0.36%
  • 7.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 66.21%
  • 0.30%
  • 7.21%
  • FII
  • DII
  • Others
  • 9.99%
  • 14.91%
  • 1.38%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.97
  • 12.73
  • 9.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.82
  • 6.70
  • -4.74

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.66
  • 8.73
  • -3.48

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 25.70
  • 25.14
  • 25.66

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.17
  • 4.88
  • 5.30

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.45
  • 16.46
  • 17.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Net Sales
1,028.44
938.10
9.63%
1,021.04
950.93
7.37%
881.84
870.29
1.33%
971.77
837.91
15.98%
Expenses
737.78
741.76
-0.54%
749.72
729.17
2.82%
732.47
663.60
10.38%
802.22
598.33
34.08%
EBITDA
290.66
196.34
48.04%
271.32
221.76
22.35%
149.37
206.69
-27.73%
169.55
239.58
-29.23%
EBIDTM
28.26%
20.93%
26.57%
23.32%
16.94%
23.75%
17.45%
28.59%
Other Income
21.33
40.35
-47.14%
31.75
32.76
-3.08%
36.83
29.48
24.93%
34.93
24.03
45.36%
Interest
2.34
0.99
136.36%
0.85
0.88
-3.41%
1.13
7.34
-84.60%
2.84
0.95
198.95%
Depreciation
33.71
32.70
3.09%
33.18
31.78
4.41%
33.02
31.16
5.97%
33.30
31.72
4.98%
PBT
275.94
203.00
35.93%
269.04
221.86
21.27%
152.05
197.67
-23.08%
168.34
230.94
-27.11%
Tax
80.64
46.40
73.79%
60.92
47.24
28.96%
29.80
46.46
-35.86%
33.83
39.16
-13.61%
PAT
195.30
156.60
24.71%
208.12
174.62
19.18%
122.25
151.21
-19.15%
134.51
191.78
-29.86%
PATM
18.99%
16.69%
20.38%
18.36%
13.86%
17.37%
13.84%
22.89%
EPS
15.46
12.18
26.93%
16.47
13.58
21.28%
9.68
11.74
-17.55%
10.46
14.70
-28.84%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
3,903.09
3,742.64
3,340.99
2,889.69
2,587.87
2,055.37
2,125.76
1,983.26
1,733.98
1,473.56
1,208.34
Net Sales Growth
8.50%
12.02%
15.62%
11.66%
25.91%
-3.31%
7.19%
14.38%
17.67%
21.95%
 
Cost Of Goods Sold
1,018.25
869.31
677.73
514.99
537.75
295.72
317.35
322.58
317.33
290.33
283.98
Gross Profit
2,884.84
2,873.33
2,663.26
2,374.70
2,050.12
1,759.65
1,808.41
1,660.68
1,416.65
1,183.23
924.36
GP Margin
73.91%
76.77%
79.71%
82.18%
79.22%
85.61%
85.07%
83.73%
81.70%
80.30%
76.50%
Total Expenditure
3,022.19
2,959.39
2,411.70
1,891.13
1,904.55
1,488.94
1,467.37
1,296.38
1,146.92
968.33
839.59
Power & Fuel Cost
-
65.71
54.38
43.70
38.88
32.65
27.42
18.70
15.49
12.91
11.20
% Of Sales
-
1.76%
1.63%
1.51%
1.50%
1.59%
1.29%
0.94%
0.89%
0.88%
0.93%
Employee Cost
-
785.14
645.78
548.25
485.59
430.71
376.47
295.42
256.64
200.58
156.97
% Of Sales
-
20.98%
19.33%
18.97%
18.76%
20.96%
17.71%
14.90%
14.80%
13.61%
12.99%
Manufacturing Exp.
-
320.81
275.42
226.20
204.81
174.78
215.80
192.70
174.40
130.81
96.29
% Of Sales
-
8.57%
8.24%
7.83%
7.91%
8.50%
10.15%
9.72%
10.06%
8.88%
7.97%
General & Admin Exp.
-
365.86
300.83
131.64
159.49
149.90
131.92
92.02
66.24
50.99
47.40
% Of Sales
-
9.78%
9.00%
4.56%
6.16%
7.29%
6.21%
4.64%
3.82%
3.46%
3.92%
Selling & Distn. Exp.
-
463.94
400.29
374.73
413.70
320.99
306.30
270.92
245.92
233.96
201.57
% Of Sales
-
12.40%
11.98%
12.97%
15.99%
15.62%
14.41%
13.66%
14.18%
15.88%
16.68%
Miscellaneous Exp.
-
88.62
57.27
51.62
64.33
84.19
92.11
104.04
70.90
48.75
201.57
% Of Sales
-
2.37%
1.71%
1.79%
2.49%
4.10%
4.33%
5.25%
4.09%
3.31%
3.49%
EBITDA
880.90
783.25
929.29
998.56
683.32
566.43
658.39
686.88
587.06
505.23
368.75
EBITDA Margin
22.57%
20.93%
27.81%
34.56%
26.40%
27.56%
30.97%
34.63%
33.86%
34.29%
30.52%
Other Income
124.84
98.64
115.68
25.98
92.19
21.08
24.16
23.86
21.15
16.80
13.71
Interest
7.16
5.84
10.20
8.27
11.91
1.16
0.41
1.36
4.89
5.92
8.73
Depreciation
133.21
130.80
125.29
116.09
95.71
72.08
59.59
61.21
44.43
51.64
43.88
PBT
865.37
745.25
909.48
900.18
667.89
514.27
622.55
648.17
558.89
464.47
329.85
Tax
205.19
157.27
196.80
246.31
196.27
127.30
153.91
141.34
143.28
146.15
95.97
Tax Rate
23.71%
21.10%
21.64%
27.36%
29.56%
24.75%
24.72%
21.81%
25.64%
32.05%
29.10%
PAT
660.18
587.98
712.68
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
PAT before Minority Interest
660.18
587.98
712.68
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
16.91%
15.71%
21.33%
22.63%
18.07%
18.83%
22.05%
25.56%
23.97%
21.03%
19.36%
PAT Growth
-2.08%
-17.50%
8.99%
39.81%
20.86%
-17.43%
-7.54%
21.95%
34.13%
32.49%
 
EPS
52.44
46.70
56.61
51.94
37.15
30.74
37.22
40.26
33.01
24.61
18.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
3,387.99
3,264.34
2,995.63
2,598.87
2,245.21
2,041.37
1,567.69
1,190.86
841.09
593.31
Share Capital
25.27
17.17
17.39
17.54
17.54
17.69
17.69
17.69
17.68
17.67
Total Reserves
3,362.38
3,246.87
2,977.70
2,580.86
2,226.57
2,022.05
1,550.00
1,173.17
822.98
575.06
Non-Current Liabilities
177.38
285.02
274.55
227.61
162.23
38.56
8.90
28.63
55.67
80.62
Secured Loans
1.25
1.64
1.60
0.74
0.66
1.01
1.04
5.79
23.31
41.53
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
9.08
9.94
10.77
Long Term Provisions
146.55
216.04
208.12
155.01
134.15
13.16
4.88
2.59
4.76
2.83
Current Liabilities
1,139.28
647.39
838.82
745.53
498.35
346.05
246.66
259.89
249.59
275.42
Trade Payables
422.77
327.17
373.86
362.34
225.18
249.63
178.18
145.57
109.06
124.54
Other Current Liabilities
669.42
301.47
214.14
180.12
111.45
63.95
46.33
56.72
58.33
47.63
Short Term Borrowings
0.00
0.00
0.00
42.85
33.34
0.00
0.00
46.25
17.90
60.55
Short Term Provisions
47.09
18.75
250.82
160.22
128.38
32.47
22.15
11.35
64.30
42.70
Total Liabilities
4,704.65
4,196.75
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35
Net Block
1,496.44
1,503.58
1,541.11
1,472.14
1,168.35
1,052.66
589.17
450.74
288.09
279.39
Gross Block
2,282.82
2,206.86
2,140.80
1,976.15
1,578.96
1,417.23
894.94
715.73
549.85
492.00
Accumulated Depreciation
786.38
703.28
599.69
504.01
410.61
364.57
305.77
264.99
261.76
212.61
Non Current Assets
1,870.65
1,932.29
1,891.22
1,790.94
1,605.27
1,202.36
972.65
716.11
512.94
429.30
Capital Work in Progress
209.47
152.86
108.19
131.86
261.61
61.33
254.22
198.91
170.20
93.55
Non Current Investment
25.10
25.10
0.00
12.28
22.87
7.58
0.00
0.00
40.04
8.46
Long Term Loans & Adv.
134.79
236.46
230.74
164.20
148.36
76.79
41.88
21.29
9.34
39.15
Other Non Current Assets
4.85
5.88
11.18
10.46
4.08
4.00
2.34
4.28
5.27
8.75
Current Assets
2,825.18
2,264.46
2,217.78
1,781.07
1,300.52
1,223.62
850.60
763.27
633.41
520.05
Current Investments
510.27
121.86
175.67
67.14
64.74
182.38
181.56
76.78
19.46
55.00
Inventories
815.63
791.07
766.47
495.68
435.71
350.63
211.02
204.58
159.03
155.40
Sundry Debtors
1,056.90
1,019.81
738.43
775.30
459.48
459.79
323.15
372.35
258.76
202.22
Cash & Bank
330.90
211.79
209.61
205.25
100.51
93.09
69.95
43.37
136.76
60.39
Other Current Assets
111.48
34.79
104.15
69.02
240.08
137.73
64.92
66.19
59.40
47.04
Short Term Loans & Adv.
89.39
85.14
223.45
168.68
143.45
23.11
56.29
59.39
47.43
43.66
Net Current Assets
1,685.90
1,617.07
1,378.96
1,035.54
802.17
877.57
603.94
503.38
383.82
244.63
Total Assets
4,695.83
4,196.75
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
791.78
561.71
576.31
456.77
374.51
281.12
609.29
326.14
279.42
212.42
PBT
745.25
909.48
900.18
663.97
514.27
622.56
648.17
558.90
456.01
329.85
Adjustment
131.30
91.75
115.27
70.79
61.93
52.48
86.33
53.07
51.21
50.82
Changes in Working Capital
66.52
-200.39
-208.75
-123.16
-83.46
-254.32
25.88
-124.34
-81.69
-74.52
Cash after chg. in Working capital
943.07
800.84
806.70
611.60
492.74
420.72
760.38
487.63
425.53
306.15
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-151.29
-239.13
-230.39
-154.83
-118.23
-139.60
-151.09
-161.49
-146.11
-93.73
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-559.60
-74.10
-282.38
-224.40
-222.78
-256.11
-383.12
-209.07
-158.36
-187.80
Net Fixed Assets
-150.65
-110.38
-137.02
-255.91
-361.08
-327.21
-235.38
-197.00
-138.00
-120.60
Net Investments
-388.41
-7.97
-71.11
7.11
107.76
-1.82
-104.79
-17.41
2.22
-59.98
Others
-20.54
44.25
-74.25
24.40
30.54
72.92
-42.95
5.34
-22.58
-7.22
Cash from Financing Activity
-107.87
-459.71
-318.29
-128.63
-147.46
-0.20
-201.77
-117.32
-105.19
-20.13
Net Cash Inflow / Outflow
124.31
27.90
-24.36
103.74
4.27
24.81
24.40
-0.25
15.87
4.49
Opening Cash & Equivalents
206.36
177.51
202.35
95.16
90.64
65.83
41.42
41.67
38.62
34.13
Closing Cash & Equivalent
330.67
205.41
177.99
198.90
94.91
90.64
65.82
41.42
54.49
38.62

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
269.07
254.80
230.83
297.80
257.19
231.78
178.14
135.31
95.57
67.42
ROA
13.21%
17.16%
17.03%
14.44%
14.52%
22.06%
30.69%
31.66%
29.57%
28.05%
ROE
17.68%
22.77%
23.38%
19.32%
18.07%
25.98%
36.75%
40.92%
43.24%
47.47%
ROCE
22.57%
29.37%
32.20%
27.44%
23.84%
34.49%
45.74%
51.61%
56.43%
54.53%
Fixed Asset Turnover
1.69
1.56
1.43
1.46
1.37
1.84
2.49
2.76
2.85
2.61
Receivable days
99.85
94.50
93.66
87.08
81.62
67.06
63.41
65.84
56.64
52.93
Inventory Days
77.25
83.71
78.09
65.68
69.82
48.10
37.89
37.93
38.64
45.48
Payable days
157.44
188.77
260.89
59.55
63.24
57.26
50.30
41.91
46.38
59.31
Cash Conversion Cycle
19.66
-10.56
-89.14
93.21
88.21
57.90
51.01
61.86
48.91
39.10
Total Debt/Equity
0.00
0.00
0.00
0.02
0.02
0.00
0.00
0.07
0.09
0.22
Interest Cover
128.61
90.16
109.85
56.75
444.34
1519.41
477.60
115.29
78.03
38.78

News Update:


  • Ajanta Pharma - Quarterly Results
    31st Oct 2023, 14:15 PM

    Read More
  • Ajanta Pharma gets USFDA’s final nod for Topiramate Extended-Release Capsules
    30th Aug 2023, 18:15 PM

    The company has received 50 final ANDA approvals, out of which 41 are commercialized

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.